MedTrace Logo

The Cytoadherence in Pediatric Malaria (CPM) Study

NCT00707200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2010-01-26

No results posted yet for this study

Summary

The purpose of this study is to determine the importance of key blood group molecules in the clinical outcome of Plasmodium falciparum malaria infection in children.

Conditions

  • Plasmodium Falciparum Malaria

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Nicolette Nabukeera-Barungi, MBChB, MMEd · Mulago Hospital/Makerere University (lead local investigator)

Eligibility

Min Age
6 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00707200 on ClinicalTrials.gov